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Background. Rapid diagnostic tests (RDTs) now play an important role in the diagnosis of falciparum malaria
in many countries where the disease is endemic. Although these tests have been extensively evaluated in
uncomplicated falciparum malaria, reliable data on their performance for diagnosing potentially lethal severe
malaria is lacking.
Methods. We compared a Plasmodium falciparum histidine-rich-protein2 (PfHRP2)–based RDT and
a Plasmodium lactate dehydrogenase (pLDH)–based RDT with routine microscopy of a peripheral blood slide
and expert microscopy as a reference standard for the diagnosis of severe malaria in 1898 children who presented
with severe febrile illness at 2 centers in Mozambique and Tanzania.
Results. The overall sensitivity, specificity, positive predictive value, and negative predictive values of the
PfHRP2-based test were 94.0%, 70.9%, 85.4%, and 86.8%, respectively, and for the pLDH-based test, the values were
88.0%, 88.3%, 93.2%, and 80.3%, respectively. At parasite counts ,1000 parasites/lL (n 5 173), sensitivity of
the pLDH-based test was low (45.7%), compared with that of the PfHRP2-based test (69.9%). Both RDTs
performed better than did the routine slide reading in a clinical laboratory as assessed in 1 of the centers.
Conclusion. The evaluated PfHRP2-based RDT is an acceptable alternative to routine microscopy for
diagnosing severe malaria in African children and performed better than did the evaluated pLDH-based RDT.
The clinical diagnosis of severe malaria is unreliable,
because signs and symptoms overlap with other life-
threatening febrile illnesses, including pneumonia, men-
ingitis, and bacterial sepsis [1–3]. Because severe malaria
kills rapidly, prompt diagnosis and management are vital
[4, 5]. On the other hand, overdiagnosis of severe malaria
in African children is common and diverts attention from
other infectious causes, which has been shown to con-
tribute to mortality [6]. A rapid and reliable parasito-
logical diagnosis of severe malaria is thus essential for
proper management of patients with severe febrile illness.
Microscopy remains the reference standard [7], but this
requires the availability of a good microscope, significant
technical skills, good-quality reagents, and clean slides.
The diagnostic quality of microscopy is highly variable in
routine hospitals in sub-Saharan Africa [8, 9].
Compared with microscopy, malaria rapid diagnostic
tests (RDTs) do not require extensive training or well-
maintained equipment. They are increasingly used for
malaria diagnosis. Malaria RDTs are immunochro-
matographic tests that identify malaria antigens, most
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commonly Plasmodium falciparum histidine-rich-protein2
(PfHRP2) or Plasmodium lactate dehydrogenase (pLDH).
Disadvantages are that test results are qualitative and do not
provide prognostic information, such as parasite staging and
neutrophil pigment [10, 11].
RDTs have been evaluated extensively for the diagnosis of
uncomplicated malaria but not for severe malaria [12], and
diagnostic test requirements are different in severe disease; eg, a
high sensitivity is of utmost importance, because missing
a case may result in inappropriate treatment and death. We
therefore compared the diagnostic performance of a commonly
used PfHRP2-based RDT (Paracheck; Orchid Biomedical) and
a pLDH-based RDT (OptiMAL-IT; DiaMed) with that of expert
microscopy, which was used as the reference standard, for
the diagnosis of severe malaria in children with severe febrile
illness who were admitted to 2 African hospitals in areas with
different malaria transmission intensities.
METHODS
The study sites were in Teule Hospital in Muheza, Tanzania, and
Hospital Central da Beira in Beira, Mozambique. The sites were
chosen because of their different transmission dynamics, be-
cause this determines the a priori probability of the diagnosis,
which influences test performance. The study was part of a large
multicenter clinical trial that compared quinine and artesunate
for the treatment of severe malaria [5]. Ethical approval was
obtained from Comite´ Nacional de Bioe´tica para a Sau´de in
Mozambique and the Tanzania Medical Research Coordinating
Committee. Written informed consent for enrolled patients was
obtained from attending relatives.
Teule Hospital is a rural 300-bed district hospital in Muheza
in North-Eastern Tanzania. Malaria transmission is high, with
an estimated Entomological Inoculation Rate (EIR) of 149 in
2000 [13]. In-patient pediatric human immunodeficiency virus
(HIV) prevalence in children presenting with febrile illnesses
was reported as 3.9% [14]. Beira Central Hospital is an 800-
bed tertiary referral hospital in Beira in Central Mozambique.
EIR has not been documented here, but the observed age dis-
tribution, including older children and occasionally including
adults, suggests significantly lower transmission intensity than
in Muheza [15]. HIV infection prevalence is high and was
reported to be 16% in adults in 2005 [16].
Children (weight,>5 kg; age,,15 years) who presented with
severe febrile illness according to modified World Health
Organization (WHO) clinical criteria for severe malaria [17]
were screened using 2 malaria RDTs and a peripheral blood
slide. Severity criteria included decreased consciousness (coma
or severe prostration), convulsions, respiratory distress or aci-
dotic breathing, shock, severe symptomatic anemia, hypogly-
cemia, hemoglobinuria, or severe jaundice. Health care workers
were trained to recognize the criteria for severe febrile illness,
perform the RDTs, and prepare a peripheral blood slide, and
they were supervised by the study site coordinator. In Tanzania,
health workers were clinical officers and nurses who were
employed for the research project. In Mozambique, hospital
nurses performed the screening as part of routine care.
Definitions
Fever was defined as an axillary temperature >37.5C or by
a history of recent fever. Coma was defined as a Blantyre Coma
Score< 2 for children,2 years of age or a Glasgow Coma Score
<10 for older children. Prostration was defined as the inability
to sit unsupported (for children .6 months of age) or the in-
ability to drink or breast-feed in younger children. Convulsions
were recorded in cases in which the duration was .30 min
or the frequency was >2 within the 24 h preceding hospital
admission. Compensated shock was defined as a peripheral
capillary refill time > 3 sec or the presence of a temperature
gradient with a normal systolic blood pressure (>70 mmHg).
Decompensated shock was defined as a systolic blood pressure
,70 mmHg. Severe respiratory distress was defined as nasal alar
flaring, costal indrawing or recession or the use of accessory
muscles, or severe tachypnoea, whereas severe acidosis was
suspected if deep breathing was present. A blood glucose level
,3 mmol/L or clinical improvement in the level of conscious-
ness immediately after administration of 10% dextrose was
regarded as hypoglycemia. Anemia was defined as severe pallor
combined with respiratory distress. Hemoglobinuria was assessed
by caretaker history or observation of dark or black discoloration
of the urine. Jaundice was assessed by clinical examination.
Sampling and Slide Reading
Paracheck test (Orchid Biomedical; Mumbai, India; 0.65 USD/
test), OptiMAL-IT test (DiaMed AG; Cressier, Switzerland; 1.70
USD/test) and peripheral blood slides were prepared from blood
samples taken by finger prick. Thin and thick blood films were
stained with 5% Giemsa for 20 min. These slides were read by
local laboratory technicians (routine practice slide reading),
with later assessment by expert microscopy at the reference
laboratory at the Mahidol Oxford Tropical Medicine Research
Unit in Bangkok, Thailand.
In Beira, the slides were read by microscopists working in the
routine hospital laboratory. These microscopists were blinded
to the RDT results and reported thick film results using a semi-
quantitative method with a 5-point scale [18]. In Muheza,
microscopists were unblinded, and hence their findings were
not included in the analysis.
Microscopists in the reference laboratory were blinded to the
RDT results. The slide findings were reported as negative if no
parasites were encountered per 500 white blood cells (WBCs)
counted. Parasitemia was quantified in the thick film if ,1
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parasite was encountered per 1000 red blood cells (RBCs) in
the thin film, using the formula parasites/lL5 (parasites/200
WBCs) 3 40, assuming a WBC count of 8000 WBCs/lL.
Parasitemia was quantified in the thin film if .5 parasites were
seen per field in the thick film, using the formula parasites/lL5
(parasites/1000 RBCs) 3 30 3 125.6, assuming a hematocrit of
30%. Slides with gametocytes but no asexual parasites were
scored as negative. Hemoglobin testing, HIV testing, and blood
cultures were not performed routinely.
Data Management and Analysis
Data were double-entered using Access database software
(Microsoft) and analyzed using Stata, version 10.0 (Stata).
Sensitivity, specificity, and positive and negative predictive val-
ues were calculated using expert laboratory microscopy as the
reference standard. Categorical variables were compared using
the v2 or Fisher’s exact test, and continuous variables were
compared using Student’s t test or the Mann-Whitney U test,
depending on the distribution of the data. Sensitivities and
specificities between methods were compared using McNemar’s
test [19]. To determine the prognostic significance of the clinical
signs and symptoms, a logistic regression model was constructed
with the positive malaria slide by the reference laboratory as
the dependent variable and the age group and signs and
symptoms of severe disease as independent variables. Age groups
,3 and >3 years were chosen on the basis of the age distribu-
tion within sites. Using a backwards stepwise approach, only
variables with P , .05 were retained in the final model.
RESULTS
From July 2005 through April 2009, 2190 patients were screened
(Figure 1). Paired PfHRP2 and pLDH test and slide results were
available for 1898 patients, after excluding 40 patients (2%) who
did not fulfill clinical severity criteria, 235 patients (10.7%) who
lacked an evaluable slide for the reference laboratory, and 17
patients (0.8%) who were without a valid PfHRP2- or pLDH-
based test result. Excluded patients did not differ with respect
to age, sex, or severity criteria.
Patients differed in age and clinical signs and symptoms be-
tween sites (Table 1). In Muheza, related to the higher malaria
transmission rate, children were younger, and severe respiratory
distress and prostration were the most frequent presenting
symptoms. Severe anemia with respiratory distress was more
prevalent at the Muheza site than it was at the Beira site. In Beira,
the most common presenting symptoms were convulsions and
coma. Hemoglobinuria and severe jaundice were rare at both
sites. Peripheral blood parasitemia at hospital admission did
not differ significantly between sites (P 5 .711).
One slide from the Muheza site showed mixed infection of
P. falciparum and P. ovale. In 141 slides (7.4%), P. falciparum
asexual parasites were detected but could not be quantified be-
cause of poor slide quality, which was most commonly caused
by precipitations of the Giemsa stain.
A total of 345 patients had disconcordant results between the 3
diagnostic tests (Table 2). Most frequent were the combinations
of a positive PfHRP2 test result and negative slide findings (in
197 [10.4%] of 1898 patients) and a negative pLDH test result
with positive slide findings (147 [7.7%] of 1898). Patients with
a positive peripheral blood slide finding and a negative PfHRP2-
based test result all also had negative pLDH-based test results.
A small number of the patients with false-positive RDT results
(5 [2.5%] of 197 PfHRP2-based test results and 1 [1.3%] of
79 pLDH-based test results) showed P. falciparum gametocytes
on the slide. The presence of gametocytes in the patients with
negative blood slide findings was associated with a positive
PfHRP2 test result (5 of 197 with false-positive results vs 1 of
480 with true negative results; P 5 .009).
The PfHRP2-based test was more sensitive than was the
pLDH-based test (94.0% vs 88.0%; P, .001), but the pLDH test
was more specific (88.3% vs 70.9%; P 5 .001). This difference
in sensitivity and specificity was observed at both sites. Both
RDTs performed better at the Muheza site than at the Beira site
(Table 3).
RDT sensitivity correlated positively with peripheral blood
parasitemia, as shown in Figure 2. The sensitivity of both tests
was ,50% with parasite counts ,100 parasites/lL. For the
PfHRP2-based test, sensitivity increased substantially with
higher parasite densities (85% at parasite counts of 100–1000
parasites/lL and.90% at parasite counts.1000 parasites/lL).
With the pLDH-based test, the sensitivity increased .90% only
at parasite densities .10,000 parasites/lL.
The peripheral blood slides assessed by hospital microscopists
in Beira were compared with slide readings of the reference
laboratory. Results were available for 861 of 874 patients. Using
expert microscopy as the reference standard, the sensitivity of
routine slide reading was significantly less than that of both
Figure 1. Study profile comparing 2 different rapid diagnostic tests
with expert microscopy in African children presenting with severe febrile
illness. PfHRP2, Plasmodium falciparum histidine-rich-protein2; pLDH,
Plasmodium lactate dehydrogenase.
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RDTs: 78.0% (95% confidence interval [CI], 74.4%–81.2%)
versus 92.2% for the PfHRP2-based test and 84.8% for the
pLDH-test (P , .001 for both). The specificity of routine
slide reading was 84.0% (95% CI, 79.0%–88.2%), which is
higher than that of the PfHRP2 test (64.9%; P, .001) and the
same as that of the pLDH test (82.5%, P5 .552). The positive
and negative predictive values of routine slide reading
using expert microscopy as a reference test were 91.8% (95%
CI, 89.0%–94.0%) and 62.5% (95% CI, 57.2%–67.6%),
respectively.
The sensitivity of the RDTs improved with increasing num-
bers of presenting signs and symptoms of severe disease (data
not shown). The sensitivity of both RDTs was highest in patients
who presented with reduced consciousness, severe anemia with
respiratory distress, and hypoglycemia (Table 4).
A logistic regression model was used to identify independent
predictors of slide positivity on the basis of clinical parameters
and age group (,3 or>3 years of age). Reduced consciousness
(adjusted odds ratio [AOR], 4.0; 95% CI, 3.2–5.1; P , .001),
and convulsions (AOR, 1.7; 95% CI, 1.3–2.3; P , .001) were
associated with slide positivity in the final model, adjusted for
site. There was a significant interaction between age and severe
anemia (P5.024), indicating a higher risk of severe anemia with
younger age (for the ,3-year-old age group: AOR, 5.8; 95% CI
3.6–9.4; P 5 .001; for the > 3-year-old age group: AOR, 2.2;
95% CI, 1.1–4.4; P 5 .024). Shock, severe respiratory distress,
Table 1. Baseline Characteristics of African Pediatric Patients with Severe Febrile Illness Screened for Severe Malaria, by Study Site
Variable Muheza (n51024) Beira (n5874) P
Data collection period Dec 2006–Mar 2008 Jul 2005–Apr 2009
Male sex 527 (51.5) 463 (53.0) .512
Age, median months (IQR) 18 (9–35) 36 (24–65) ,.001
Presenting symptoms
Severity criteria per patient, median no. of criteria (range) 2 (1–7) 2 (1–6) .006
Coma 177 (17) 417 (48) ,.001
Prostration 412 (40) 338 (39) .488
Convulsions 211 (21) 724 (83) ,.001
Decompensated shock 16 (2) 10 (1) .434
Compensated shock 76 (7) NAa
Severe respiratory distress and/or acidotic breathing 636 (62) 27 (3) ,.001
Hypoglycemia 109 (11) 36 (4) ,.001
Severe anemia with respiratory distress 156 (15) 85 (10) ,.001
Hemoglobinuria 3 (,1) 16 (2) .001
Severe jaundice 12 (1) 17 (2) .171
Slide results/parasitemia
Slide negative 409 (40) 268 (31) ,.001
Slide positive 530 (52) 550 (63)
Slide positive but no Pf count 85 (8) 56 (6)
Geometric mean parasites/lLb(95% CI) 35,196 (27,533–44,990) 32,974 (25,841–42,076) .711
NOTE. Data are no. (%) of patients, unless otherwise indicated. CI, confidence interval; IQR, interquartile range; Pf, Plasmodium falciparum.
a Compensated shock was not recorded at the moment of screening in Beira.
b From slide-positive patients with Pf count.
Table 2. Rapid Diagnostic Test Results Compared with Expert Microscopy Findings
Variable Slide positive (n51221) Slide negative (n5677)
pLDH positive pLDH negative pLDH positive pLDH negative
pfHRP2 positive 1074 74 78 119
pfHRP2 negative 0 73 1 479
NOTE. PfHRP2, Plasmodium falciparum histidine-rich-protein2; pLDH, Plasmodium lactate dehydrogenase.
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hypoglycemia, hemoglobinuria, and severe jaundice were not
independent predictors of slide positivity.
Discussion
This is a large comparative study of RDTs for diagnosing severe
malaria in severely ill children presenting to African hospitals.
In our evaluation, the PfHRP2-based test was a reliable alter-
native to routine microscopy for the diagnosis of pediatric severe
malaria and was more sensitive than was the pLDH-based
RDT, but this was at the expense of a lower specificity. The
PfHRP2-based test sensitivity of 96.9% (95% CI, 95.7%–97.9%)
for parasite densities .100 parasites/lL is above the WHO-
recommended threshold of 95% [20]. The pLDH-based test had
a sensitivity of 91.2% (95% CI, 89.3%–92.9%) for parasite
densities.100 parasites/lL. Severe malaria requires a diagnostic
test with high sensitivity, because missing the diagnosis and
withholding treatment may well cause death. Conversely, sub-
optimal specificity leads to underdiagnosis of other severe in-
fections [6, 21].
It should be reminded that, even with slide-proven severe
malaria, a substantial proportion of children have concomitant
invasive bacterial infections that warrant antimicrobial treat-
ment [14, 22].
The a priori probability of severe malaria depends on malaria
transmission intensity and the prevalence of alternative diseases
causing severe febrile illnesses, notably HIV/AIDS. Because HIV/
AIDS prevalence is high in sub-Saharan Africa, including
Mozambique [16], and with decreasing malaria transmission in
several African countries [23], alternative diagnoses will become
increasingly prevalent. In our study, all children met at least 1
of the WHO-defined criteria for severe malaria [17], but these
clinical signs did not have a strong predictive value for periph-
eral blood parasitemia, confirming the findings from earlier
studies [6]; only reduced consciousness had a predictive value
for the diagnosis. Severe anemia was more common in the
younger age group, as reported in other studies [24, 25].
We identified only 2 small studies that evaluated RDT per-
formance for the diagnosis of severe or cerebral malaria [12, 26],
whereas numerous studies have compared the performance of
various PfHRP2-based and pLDH-based RDTs in the laboratory
or for diagnosis of uncomplicated malaria in the field. The
Table 3. Comparison of the Performance of 2 Malaria Rapid Tests for the Diagnosis of Pediatric Severe Falciparum Malaria Compared
with Expert Microscopy as the Reference Standard
Variable Muheza (n51024) Beira (n5874) Combined (n51898)
Slide positive 615 (60) 606 (69) 1221 (64)
pfHRP2-based test
PfHRP2-based test positive 692 (68) 653 (75) 1345 (71)
Sensitivity, % (95% CI) 95.8 (93.9–97.2) 92.2 (89.8–94.3) 94.0 (92.5–95.3)
Specificity, % (95% CI) 74.8 (70.3–79.0) 64.9 (58.9–70.6) 70.9 (67.3–74.3)
Positive predictive value, % (95% CI) 85.1 (82.2–87.7) 85.6 (82.7–88.2) 85.4 (83.4–87.2)
Negative predictive value, % (95% CI) 92.2 (88.7–94.8) 78.7 (72.7–83.9) 86.8 (83.7–89.5)
pLDH-based test
pLDH-based test positive 592 (58) 561 (64) 1153 (61)
Sensitivity, % (95% CI) 91.1 (88.5–93.2) 84.8 (81.7–87.6) 88.0 (86.0–89.7)
Specificity, % (95% CI) 92.2 (89.1–94.6) 82.5 (77.4–86.8) 88.3 (85.7–90.7)
Positive predictive value, % (95% CI) 94.6 (92.5–96.3) 91.6 (89.0–93.8) 93.2 (91.5–94.5)
Negative predictive value, % (95% CI) 87.3 (83.8–90.3) 70.6 (65.2–75.6) 80.3 (77.2–83.1)
NOTE. CI, confidence interval; PfHRP2, Plasmodium falciparum histidine-rich-protein2; pLDH, Plasmodium lactate dehydrogenase.
Figure 2. RDT sensitivity according to the level of peripheral blood
parasitaemia (expressed as log10 parasites/lL) from n51080 patients
with positive slide and parasite count. d, Plasmodium lactate de-
hydrogenase (pLDH)-based test;s, Plasmodium falciparum histidine-rich-
protein2 (PfHRP2)-based test. Bars represent 95% confidence intervals.
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WHO and the Foundation for Innovative New Diagnostics
(FIND) evaluated 68 RDT, including both RDTs used in our
study [10, 11]. Although assessed under laboratory conditions,
the FIND evaluation confirmed that, with parasite counts,200
parasites/lL, detection rates decreased substantially for most
RDTs. The WHO/FIND recommendation for RDT pro-
curement requires a minimum detection score of 50% at
a P. falciparum parasite count of 200 parasites/lL [27]. The
pfHRP2-based test evaluated in our study complied with this,
whereas the pLDH-based test did not.
In field studies evaluating pfHRP2- and pLDH-based RDTs
for the diagnosis of uncomplicated malaria, some studies report
sensitivities.95% for both RDTs [28–31], but most studies that
directly compare PfHRP2 with pLDH-based tests confirm
a higher sensitivity (and lower specificity) for RDTs detecting
PfHRP2 [32]. For example, a study by Hopkins et al [33] found
a sensitivity of 92% for a PfHRP2-based test and 85% for
a pLDH-based test, which was mainly attributable to a better
performance of the PfHRP2-based test at low parasite densities.
Although, in our evaluation, both RDTs performed poorly at
very low parasite densities, even at very low parasite densities,
the sensitivity of the PfHRP2-based test was significantly better,
and this better performance was apparent at parasite counts up
to 100,000 parasites/lL (Figure 2).
The persistence of PfHRP2 in the bloodstream for an ex-
tended period of up to 1 month following successful malaria
parasite clearance is well documented [34–36]. This is in
contrast with the kinetics of pLDH, in which enzyme activity
is no longer detectible after parasite clearance [37], which
contributes to the higher specificity of the pLDH test. In
addition, gametocytes are known to produce PfHRP2, which
contributes to false-positive PfHRP2 test results [38, 39]. Indeed,
in patients with negative slide findings, the presence of game-
tocytes was associated with false-positive PfHRP2-based test
results.
False-negative PfHRP2-based test results occurred in 1% of
patients with parasite counts .100,000 parasites/lL, including
1 patient with a parasite count of 1,073,880 parasites/lL. This
could be related to the so-called prozone effect that has been
reported for PfHRP2-based RDTs, which is the phenomenon
that an excess of either antigen or antibodies can cause a false-
negative test result. The prozone effect has not been observed
in association with pLDH-based tests [40]. Alternative expla-
nations for false-negative RDT results are PfHRP2 gene poly-
morphisms that potentially change the antigenicity of PfHRP2
[41–43]. This has also been postulated for the gene encoding
pLDH but, to date, this has not been substantiated.
RDT performance was better at the site in Tanzania than
at the site in Mozambique. Most likely, these differences are
explained by operator-related issues, because in Tanzania, the
tests were operated by research staff. A contributing factor couldTa
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have been that the pLDH-based test was perceived as more
complicated to operate, because it requires multiple steps [10,
11, 31]. Additionally, weak positive results are easier to detect
with the PfHRP2-based test, in which a thin test band can be
observed, than with the pLDH-based test, in which a faint test
band indicates a weak positive result.
A limitation of our study was the presence of only a single
observer to report the RDT result and the absence of batch or
stability testing. However, the RDTs were shipped to the study
sites by cold-chain transport, and the study site coordinator and
the independent monitor assured that batches were used within
the expiration date, as well as stored in air-conditioned, tem-
perature-controlled rooms. The PfHRP2-based tests are rela-
tively heat-stable, but some of the pLDH-based tests, particularly
the one evaluated in this study, are known to be heat-unstable
[10, 11, 31]. At both study sites, the staff were regularly trained
and supervised in slide preparation and RDT operation.
RDTs have mainly been promoted for outpatient manage-
ment of uncomplicated malaria, but the challenges of micros-
copy in sub-Saharan Africa are likely to extend their use to
inpatient settings [8, 44]. At the study site in Mozambique,
which is a tertiary care center with experienced microscopists,
the sensitivity of routine microscopy was significantly lower than
that of both RDTs, despite the provision of good quality reagents
and training. Where the current WHO guidelines leave un-
certainty about the best method for a parasitological diagnosis of
severe malaria in young children, the findings of our study
suggest that a PfHRP2-based RDT is considerably better than
routine microscopy. To optimize the diagnosis of severe malaria
and severe illness, a diagnostic algorithm could be employed in
which only negative RDT results should be confirmed by reliable
microscopy. A reduction in the workload of the hospital labo-
ratory could improve microscopy quality. A negative RDT result
should trigger contemplation of an alternative diagnosis. A
positive RDT result does not exclude co-existing bacterial in-
fections, and antimicrobial treatment is recommended.
In conclusion, this study shows that the PfHRP2-based RDT is
a reliable and easy-to-perform alternative to routine microscopy
for the diagnosis of severe malaria in African children and
performs better than does a pLDH-based test.
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